ESP vs VRTX · P/E 15, rev $9.6M vs P/E 30, rev $12.00B
Espey Mfg & Electronics Corp (ESP) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Espey Mfg & Electronics Corp (ESP) is a electrical equipment & parts company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ESP revenue for 2025-06-30 was $9.6M. Net income was $2.9M. Revenue was down 6.9% from 2025-03-31 to 2025-06-30. ESP currently screens at market cap $173.6M and trailing P/E 15.2.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ESP currently screens at market cap $173.6M and trailing P/E 15.2. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ESP and VRTX stock pages for the full models.
Not investment advice.